ATE126445T1 - Klebende vorrichtung zur transdermalen verabreichung eines wirkstoffs. - Google Patents

Klebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.

Info

Publication number
ATE126445T1
ATE126445T1 AT91105933T AT91105933T ATE126445T1 AT E126445 T1 ATE126445 T1 AT E126445T1 AT 91105933 T AT91105933 T AT 91105933T AT 91105933 T AT91105933 T AT 91105933T AT E126445 T1 ATE126445 T1 AT E126445T1
Authority
AT
Austria
Prior art keywords
cir
plaster layer
ingredient
active substance
transdermal administration
Prior art date
Application number
AT91105933T
Other languages
English (en)
Inventor
Akihito Yamanaka
Saburo Otsuka
Yoshifumi Hosaka
Original Assignee
Nitto Denko Corp
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp, Takeda Chemical Industries Ltd filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of ATE126445T1 publication Critical patent/ATE126445T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91105933T 1990-04-18 1991-04-13 Klebende vorrichtung zur transdermalen verabreichung eines wirkstoffs. ATE126445T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2104294A JP2849937B2 (ja) 1990-04-18 1990-04-18 医療用貼付剤

Publications (1)

Publication Number Publication Date
ATE126445T1 true ATE126445T1 (de) 1995-09-15

Family

ID=14376914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91105933T ATE126445T1 (de) 1990-04-18 1991-04-13 Klebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.

Country Status (7)

Country Link
US (1) US5176916A (de)
EP (1) EP0452837B1 (de)
JP (1) JP2849937B2 (de)
AT (1) ATE126445T1 (de)
CA (1) CA2040698A1 (de)
DE (1) DE69112108T2 (de)
ES (1) ES2075249T3 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248676A (en) * 1990-05-17 1993-09-28 Hisamitsu Pharmaceutical Co., Inc. Estradiol percutaneous administration preparations
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP3523275B2 (ja) * 1992-03-26 2004-04-26 東光薬品工業株式会社 貼付剤
WO1993023019A1 (en) * 1992-05-11 1993-11-25 Sri International Transdermal drug delivery systems and related compositions and methods of use
US6162456A (en) * 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5919478A (en) * 1993-06-25 1999-07-06 Alza Corporation Incorporating poly-N-vinyl amide in a transdermal system
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
US5552153A (en) * 1994-04-28 1996-09-03 Hoffman-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
EP0788794A4 (de) * 1994-08-09 2000-06-28 Tsumura & Co Mittel zur externen anwendung
CA2198390C (en) * 1994-09-14 2009-08-11 James E. Garbe Matrix for transdermal drug delivery
AU685673B2 (en) * 1994-09-16 1998-01-22 Hisamitsu Pharmaceutical Co., Inc. Patch for external use
JP3947564B2 (ja) 1994-10-28 2007-07-25 キンバリー クラーク ワールドワイド インコーポレイテッド 接着剤付き吸収性物品
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
US5686083A (en) * 1994-12-08 1997-11-11 Schering-Plough Healthcare Products Inc. Compositions for treating corns and calluses
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
DE19512181C2 (de) 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
FR2739031B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
US5755758A (en) * 1995-11-07 1998-05-26 Medtronic, Inc. Intramuscular stimulation lead with enhanced infection resistance
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DK48997A (da) * 1997-04-30 1999-01-05 Coloplast As Klæbemiddel samt anvendelse af dette middel
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
EP0891782B1 (de) * 1997-07-17 2005-05-25 Nitto Denko Corporation Medizinische Selbstklebefolie und Verfahren zu deren Herstellung
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
WO1999032153A1 (en) 1997-12-22 1999-07-01 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
DE19800277B4 (de) * 1998-01-07 2004-09-02 Lts Lohmann Therapie-Systeme Ag Verfahren zur Rückgewinnung von Arzneistoffen aus Zubereitungen, deren Vorprodukten oder Abfällen
US6146656A (en) * 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
US6193996B1 (en) 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
IT1309588B1 (it) * 1999-03-05 2002-01-24 Altergon Sa Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
DE19918105C1 (de) * 1999-04-22 2000-09-21 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6733785B1 (en) * 1999-06-11 2004-05-11 Lintec Corporation Moisture-sensitive preparation of percutaneous absorption type
KR100686527B1 (ko) 1999-07-15 2007-02-27 히사미쓰 세이야꾸 가부시키가이샤 경피흡수제제
US6673826B2 (en) 1999-07-23 2004-01-06 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020054895A1 (en) 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US6896897B2 (en) * 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US6864274B2 (en) * 1999-07-23 2005-03-08 Alwyn Company, Inc. Allantoin-containing skin cream
US20020055531A1 (en) * 1999-07-23 2002-05-09 Elliott Farber Methods for treatment of inflammatory diseases
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
ATE424817T1 (de) * 2000-09-19 2009-03-15 Dermal Therapy Barbados Inc Topische analgetische zusammensetzungen enthaltend aliphatische polyamine und methoden für ihre verwendung
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
BRPI0210074B1 (pt) * 2001-05-31 2017-05-30 Hisamitsu Pharmaceutical Co emplastro de anti-inflamatórios não esteroidais percutaneamente absorvível, contendo sais de amônio, promotores de permeação e/ou agentes de solubilização em uma camada de substrato adesivo
US7842752B2 (en) 2003-09-02 2010-11-30 Coloplast A/S Adhesive composition
JP4268527B2 (ja) * 2004-01-16 2009-05-27 積水化学工業株式会社 外用治療シート
US20080138388A1 (en) * 2005-02-04 2008-06-12 Hisamitsu Pharmaceutical Co., Inc. Transdermal Absorption Patch
DE102005058166A1 (de) 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
US20090017120A1 (en) * 2007-03-23 2009-01-15 Humco Holding Group, Inc. Phase stable lecithin organogel composition
US8182647B2 (en) 2007-07-23 2012-05-22 Cohera Medical, Inc. Hydrophilic biodegradable adhesives
AU2010319065B2 (en) * 2009-11-12 2015-03-26 Nihon University Pharmaceutical composition for external use
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
ES2608782T3 (es) 2010-04-30 2017-04-17 Teikoku Pharma Usa, Inc. Composiciones transdérmicas de propinilaminoindano
EP2688561B1 (de) 2011-03-24 2018-08-22 Teikoku Pharma USA, Inc. Transdermale zusammensetzungen mit einer wirkstoffschicht und einer wirkstoffumwandlungsschicht
FR2975002B1 (fr) * 2011-05-12 2020-08-14 Jean-Noel Thorel Procede de traitement cosmetique de la peau en deux etapes successives
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
AU2013338243B2 (en) 2012-11-02 2016-09-29 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions
BR112016003675B1 (pt) * 2013-08-23 2022-11-22 Hisamitsu Pharmaceutical Co., Inc Cataplasma e método para produzir o mesmo
KR101948779B1 (ko) 2013-10-07 2019-05-21 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
CA2924233C (en) 2013-10-07 2018-10-23 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
CA2924236C (en) 2013-10-07 2020-01-07 Teikoku Pharma Usa, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
US9974754B2 (en) 2013-12-18 2018-05-22 Maruishi Pharmaceutical Co., Ltd. Hydrous adhesive patch
WO2016104227A1 (ja) 2014-12-22 2016-06-30 久光製薬株式会社 パップ剤
JP6632810B2 (ja) * 2015-03-31 2020-01-22 小林製薬株式会社 外用医薬組成物
BR112019006955A2 (pt) 2016-10-31 2019-07-02 Teikoku Pharma Usa Inc métodos de controle da dor usando dispositivos de distribuição transdérmica de dexmedetomidina
JP7219623B2 (ja) * 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2045618B (en) * 1979-04-03 1983-05-11 Hisamitsu Pharmaceutical Co Adhesive plaster
JPH0614957B2 (ja) * 1983-06-20 1994-03-02 帝国製薬株式会社 テ−プ状含水貼付剤及びその製造方法
JPS6124517A (ja) * 1984-07-11 1986-02-03 Nichiban Co Ltd 循環器疾患用貼布治療製剤
JPS61221121A (ja) * 1985-03-27 1986-10-01 Nitto Electric Ind Co Ltd テ−プ製剤
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4732808A (en) * 1985-11-14 1988-03-22 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive sheet material
US4983396A (en) * 1985-12-06 1991-01-08 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
KR950013750B1 (ko) * 1986-08-20 1995-11-15 테이고쿠 세이야쿠 가부시키가이샤 스테로이드제 함유 외용 첩부제(貼付劑)
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
EP0359004A1 (de) * 1988-09-05 1990-03-21 Takeda Chemical Industries, Ltd. Transdermale therapeutische Zubereitung zur Behandlung von Hypertonie

Also Published As

Publication number Publication date
JP2849937B2 (ja) 1999-01-27
US5176916A (en) 1993-01-05
EP0452837A3 (en) 1992-03-04
DE69112108T2 (de) 1996-01-11
DE69112108D1 (de) 1995-09-21
CA2040698A1 (en) 1991-10-19
EP0452837B1 (de) 1995-08-16
EP0452837A2 (de) 1991-10-23
JPH041127A (ja) 1992-01-06
ES2075249T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
ATE126445T1 (de) Klebende vorrichtung zur transdermalen verabreichung eines wirkstoffs.
US3598122A (en) Bandage for administering drugs
DK0550641T3 (da) Dispenseringsanordning indeholdende et hydrofobt medium
DE3773468D1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
DK0436370T3 (da) Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf
DK156289D0 (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
PT922453E (pt) Preparacao do tipo de absorcao percutanea contendo tulobuterol
SG50517A1 (en) External preparation for aplication to the skin containg lidocine
JPH0220606B2 (de)
ZA946698B (en) Medical device for the administration of active ingredients or drugs at very low doses particularly homeopathic drugs
KR890003361A (ko) 클레보프리드 함유 피부침투용 첩제
ATE251641T1 (de) Pharmazeutische zusammensetzungen mit kontinuierlicher abgabe, die mit wasserlöslichen polymeren kovalent gebundene polypeptide enthalten
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
IE882898L (en) Solubility modulated drug delivery device
ES2007240A6 (es) Procedimiento para elaborar un preparado farmaceutico que asegura la absorcion transdernal del ingrediente activo.
SE9202066L (sv) Prokaterol-haltigt preparat foer paafoering paa huden
DE58906232D1 (de) Azelastin enthaltende Arzneimittel mit kontrollierter Wirkstoffabgabe.
JPS6468316A (en) External plaster containing salbutamol
EP0236002A3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
US4834980A (en) Transdermal delivery of azatidine
JPS5721317A (en) Plaster
DK0416722T3 (da) Farmaceutiske præparater med differentieret medikamentfrigivelseshastighed
DE3688355D1 (de) Fester koerper mit ueberzogenem kern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties